Most Recent Guidelines for Managing Hypertension
The 2024 European Society of Cardiology (ESC) guidelines recommend a target systolic blood pressure of 120-129 mmHg for most adults with hypertension to reduce cardiovascular disease risk. 1
Diagnosis and Blood Pressure Measurement
- Hypertension is defined as persistent systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥90 mmHg
- Multiple office BP measurements are the gold standard for diagnosis
- Self-monitoring and ambulatory blood pressure monitoring (ABPM) can aid in diagnosis and long-term monitoring
- BP exhibits seasonal variation with lower levels at higher temperatures and higher at lower temperatures (average decline of 5/3 mmHg systolic/diastolic in summer) 1
Treatment Thresholds
Confirmed BP ≥140/90 mmHg: Prompt initiation of lifestyle measures and pharmacological treatment regardless of cardiovascular risk 1
BP 130-139/80-89 mmHg:
- After 3 months of lifestyle intervention, pharmacological treatment is recommended for those with high cardiovascular risk (≥10% 10-year risk) 1
- The 2024 ESC guidelines expand this recommendation to include those with established CVD, hypertension-mediated organ damage, diabetes, moderate/severe CKD, or familial hypercholesterolemia 1
Treatment Targets
- Most adults: Target SBP 120-129 mmHg 1
- If poorly tolerated: Target "as low as reasonably achievable" (ALARA principle) 1
- Special populations:
Lifestyle Modifications
All patients with elevated BP should implement the following lifestyle changes:
Diet:
- Salt reduction (avoid added salt and high-sodium processed foods)
- Mediterranean or DASH diet (rich in whole grains, fruits, vegetables, polyunsaturated fats)
- Restrict free sugar consumption to <10% of energy intake
- Avoid sugar-sweetened beverages 1
Physical Activity:
- Regular aerobic exercise (150-300 minutes/week of moderate-intensity or 75-150 minutes/week of vigorous-intensity)
- Complement with resistance training 2-3 times/week 1
Weight Management:
- Aim for BMI 20-25 kg/m²
- Waist circumference <94 cm in men and <80 cm in women 1
Alcohol Consumption:
- Limit to <100g/week of pure alcohol (approximately 2 standard drinks/day for men, 1.5 for women)
- Preferably avoid alcohol consumption entirely 1
Smoking Cessation:
- Complete cessation recommended with referral to smoking cessation programs 1
Pharmacological Treatment
First-Line Medications
The following drug classes are recommended as first-line treatments 1, 2:
- ACE inhibitors (e.g., lisinopril, ramipril)
- ARBs (e.g., losartan, valsartan)
- Dihydropyridine calcium channel blockers (e.g., amlodipine)
- Thiazide/thiazide-like diuretics (e.g., chlorthalidone, indapamide)
Treatment Strategy
Initial therapy: Combination BP-lowering treatment is recommended for most patients with confirmed hypertension (BP ≥140/90 mmHg) 1
- Preferred combinations: RAS blocker (ACE inhibitor or ARB) with either a dihydropyridine CCB or diuretic
- Fixed-dose single-pill combinations are recommended for better adherence
If BP not controlled with two drugs: Add a third drug, typically a RAS blocker + dihydropyridine CCB + thiazide/thiazide-like diuretic, preferably as a single-pill combination 1
Beta-blockers: Recommended when there are specific indications (angina, post-myocardial infarction, heart failure with reduced ejection fraction, or heart rate control) 1, 2
Important caution: Combining two RAS blockers (ACE inhibitor and ARB) is not recommended 1
Special Populations
Non-Black patients: Start with ACE inhibitor/ARB, add dihydropyridine CCB, then add thiazide/thiazide-like diuretic 2
Black patients: Start with ARB plus CCB, or CCB plus thiazide diuretic 2
Diabetes and CKD: First choice is ACE inhibitor or ARB 2
Elderly patients (≥75 years): Target BP <140/90 mmHg, use simplified regimens, monitor for orthostatic hypotension 2
Common Pitfalls and Caveats
Medication adherence: Poor adherence affects 10-80% of hypertensive patients and is a key driver of suboptimal BP control 1
- Take medications at the most convenient time of day to establish a habitual pattern
- Use fixed-dose combinations when possible
Seasonal BP variation: Consider adjusting treatment during significant temperature changes, as BP tends to be higher in cold weather and lower in warm weather 1
Medication interactions: Be cautious with NSAIDs (can reduce effectiveness of ACE inhibitors, ARBs, and diuretics) and potassium supplements (can increase risk of hyperkalemia with ACE inhibitors, ARBs, and aldosterone antagonists) 2
Monitoring: Check renal function and potassium within 1-2 weeks of initiating ACE inhibitors and ARBs 2
Lifelong treatment: BP-lowering drug treatment should be maintained lifelong, even beyond age 85, if well tolerated 1